The impact of asymmetric dimethylarginine (ADAMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage
A Szlachcic, G Krzysiek-Maczka… - Current …, 2013 - ingentaconnect.com
This review was designed to provide an update on the role of asymmetric arginine (ADMA),
the endogenous inhibitor of nitric oxide (NO) synthase in the pathophysiology of the upper …
the endogenous inhibitor of nitric oxide (NO) synthase in the pathophysiology of the upper …